HealthEquity (NASDAQ:HQY) Price Target Raised to $72.00 at Deutsche Bank Aktiengesellschaft

HealthEquity (NASDAQ:HQYGet Rating) had its price target boosted by Deutsche Bank Aktiengesellschaft from $68.00 to $72.00 in a research report released on Tuesday, The Fly reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.

A number of other equities research analysts also recently weighed in on HQY. StockNews.com downgraded shares of HealthEquity from a hold rating to a sell rating in a research note on Friday, January 6th. Raymond James raised their target price on shares of HealthEquity from $75.00 to $85.00 and gave the company an outperform rating in a research note on Monday, December 12th. Jefferies Financial Group lifted their price target on shares of HealthEquity from $80.00 to $90.00 in a research note on Wednesday, November 2nd. Royal Bank of Canada lifted their price target on shares of HealthEquity from $70.00 to $75.00 in a research note on Monday, December 5th. Finally, Robert W. Baird lifted their price target on shares of HealthEquity to $75.00 in a research note on Monday, December 12th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of Moderate Buy and an average price target of $81.54.

HealthEquity Price Performance

HQY stock opened at $57.13 on Tuesday. The firm has a 50 day moving average of $61.29 and a 200-day moving average of $64.57. The firm has a market capitalization of $4.84 billion, a P/E ratio of -81.61, a price-to-earnings-growth ratio of 2.95 and a beta of 0.80. The company has a current ratio of 3.01, a quick ratio of 3.01 and a debt-to-equity ratio of 0.48. HealthEquity has a 12 month low of $49.69 and a 12 month high of $79.20.

HealthEquity (NASDAQ:HQYGet Rating) last announced its earnings results on Tuesday, December 6th. The company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $0.01. The business had revenue of $216.09 million for the quarter, compared to the consensus estimate of $206.58 million. HealthEquity had a negative net margin of 7.07% and a positive return on equity of 2.82%. As a group, sell-side analysts predict that HealthEquity will post 0.74 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Gayle Furgurson Wellborn sold 5,237 shares of HealthEquity stock in a transaction on Wednesday, December 14th. The shares were sold at an average price of $62.00, for a total value of $324,694.00. Following the transaction, the director now directly owns 12,023 shares of the company’s stock, valued at $745,426. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.80% of the stock is owned by insiders.

Institutional Trading of HealthEquity

Several large investors have recently added to or reduced their stakes in HQY. Private Trust Co. NA bought a new stake in HealthEquity in the second quarter valued at $28,000. Assetmark Inc. boosted its holdings in HealthEquity by 387.1% in the second quarter. Assetmark Inc. now owns 755 shares of the company’s stock valued at $46,000 after acquiring an additional 600 shares in the last quarter. Eagle Bay Advisors LLC boosted its holdings in HealthEquity by 137.8% in the second quarter. Eagle Bay Advisors LLC now owns 1,108 shares of the company’s stock valued at $68,000 after acquiring an additional 642 shares in the last quarter. Wipfli Financial Advisors LLC bought a new stake in HealthEquity in the third quarter valued at $69,000. Finally, Benjamin F. Edwards & Company Inc. boosted its holdings in HealthEquity by 31.3% in the third quarter. Benjamin F. Edwards & Company Inc. now owns 1,049 shares of the company’s stock valued at $70,000 after acquiring an additional 250 shares in the last quarter. Institutional investors own 99.54% of the company’s stock.

HealthEquity Company Profile

(Get Rating)

HealthEquity, Inc provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives.

Featured Articles

The Fly logo

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.